ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …

Continue ›››

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …

Continue ›››

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …

Continue ›››

Application of AI-driven Xanthos Platform for Designing Protein Degraders

In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …

Continue ›››

Cyclica's Chemical Probes for DCAF1

Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …

Continue ›››

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

This is a sponsored case study republished from ScienceExchange.com Over the past decade, the biopharmaceutical industry has undergone a massive …

Continue ›››

Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness

Sponsored by Biocompare.com Every marketer feels pressure to demonstrate results for their marketing spend. Executives in the life sciences industry …

Continue ›››

Bioz Badges — Advanced Data-Widgets for Confident E-commerce

Bioz provides advanced life science experimentation insights to scientists in two key formats, first on the Bioz platform which showcases …

Continue ›››